Mizuho Financial Inc logo

8411 - Mizuho Financial Inc News Story

¥139.9 7.0  5.3%

Last Trade - 7:00am

Large Cap
Market Cap £25.62bn
Enterprise Value £31.46bn
Revenue £19.89bn
Position in Universe 30th / 3862

Deutsche Bank AG FF - Post Stabilisation Notice - Fresenius Medical Care

Mon 22nd June, 2020 5:02pm
RNS Number : 7068Q
Deutsche Bank AG, Frankfurt
22 June 2020



Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in

which such distribution would be unlawful.


Fresenius Medical Care AG & Co KGaA

Post-stabilisation Period Announcement


Further to the pre-stabilisation period announcement dated 19/05/201 Deutsche Bank AG (contact: DCM Syndication TA; telephone: 0207 54 54153 hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority)2 was undertaken by the Stabilisation Manager(s)3 named below in relation to the offer of the following securities.


The Securities:


Issuer:                                                                             Fresenius Medical Care AG & Co KGaA


Guarantor (if any):                                                        Fresenius Medical Care Holdings, Inc.


Aggregate nominal amount:                                       EUR 1.25 Billion


Description:                                                                   Fresenius Medical Care 6yr & 10yr EUR1.25bn dual-tranche


Stabilisation Manager(s):                                            Commerzbank, Deutsche Bank, Mizuho, Societe       Generale                          


Offer Price:                                                                     99.405% / 99.742%





This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.